O'ROURKE & COMPANY, Inc - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 3 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
O'ROURKE & COMPANY, Inc ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$211
-33.0%
7,860
-10.9%
0.15%
-30.3%
Q2 2023$315
+38.2%
8,821
-1.8%
0.22%
+27.0%
Q1 2023$228
-37.4%
8,981
-0.1%
0.17%
-39.8%
Q4 2022$364
-99.9%
8,986
-4.7%
0.29%
+6.2%
Q3 2022$312,000
-6.0%
9,4280.0%0.27%
-3.5%
Q2 2022$332,000
-23.9%
9,428
-0.6%
0.28%
-6.0%
Q1 2022$436,000
-30.9%
9,488
-0.3%
0.30%
-28.7%
Q4 2021$631,0009,5180.42%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2023
NameSharesValueWeighting ↓
Western Financial Corp/CA 820,320$33,272,17921.56%
Aquilo Capital Management, LLC 1,103,515$44,758,56816.81%
M28 Capital Management LP 143,900$5,836,5845.56%
WEALTH EFFECTS LLC 155,620$6,311,9513.60%
Evolutionary Tree Capital Management, LLC 92,095$3,735,3733.59%
Privium Fund Management B.V. 221,015$8,867,1223.36%
JOHNSON & JOHNSON 247,598$10,0432.92%
COMMODORE CAPITAL LP 462,111$18,7432.82%
Avidity Partners Management LP 1,375,000$55,770,0001.21%
Capital Impact Advisors, LLC 26,853$1,089,1581.06%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders